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Bovine pneumonic pasteurellosis is an economically important 
disease to the livestock industry (Jensen, 1968). Pasteurella haemo-
lytica biotype A serotype 1 is a frequently isolated bacteria from the 
lungs of cattle with fibrinous pneumonia and is considered the major 
pathogenic bacterial species of the disease (Jubb, Kennedy and Palmer, 
1985). The pathogenesis of the disease is still unknown, but currently 
many investigators are separating and defining the antigenic components 
of the bacterial products in an attempt to understand immunity to~ 
haemolytica. 
The leukotoxin produced by~ haemolytica has been studied and 
partially characterized by a number of investigators (Baluyut, et al., 
1981; ~osier, et al., 1983; Maheswaran, et al., 1980; Chang, et al., 
1986a; Shewen and Wilkie, 1982). The gene producing the leukotoxin has 
been cloned by Lo, et al. (1985). Other antigenic preparations have 
been studied. These preparations include outer membrane proteins 
(Squire, Smiley and Croskell, 1984), and capsular-rich antigens 
(Gilmour, et al., 1979; Gentry, Corstvet and Panciera, 1982; Yates, 
Stockdale and Babiuk, 1983; Lessley, et al., 1985; Confer, et al., 
1985b; McKinney, et al., 1985; Donachie, et al., 1984). 
'1onoclonal antibody technology has given many new insights into 
disease processes at the immunological and molecular level (Goding, 
1 
2 
1983). It is a technology in which splenic lymphocytes from hyper-
immunized mice are fused with myeloma cells to produce hybrid cells. 
These cells secrete antibody of a given specificity. 
With the combination of~ haemolytica antigen preparations and 
monoclonal antibody technology, the exploration into the pathogenesis of 
~ haemolytica can now be extended to the molecular level. In this 
study, monoclonal antibodies to a component of the bacterial cell have 
been produced and characterized. 
CHAPTER II 
LITERATURE REVIE\-1 
Bovine pneumonic pasteurellosis, also called bovine shipping fever, 
frequently occurs soon after such stressful situations as transport, 
dietary adaptation, and grouping in new, and many times, crowded 
environments (Dyer, 1982; Jubb, Kennedy and Palmer, 1985). It is a 
disease that is a severe economic liability to the beef industry 
(Jensen, 1968) despite management practices implemented to decrease 
stressful factors that may predispose to this disease (Dyer, 1982). 
Although many factors and ·etiologies may contribute to disease develop-
ment, it is unclear as to the relationship of stress, bacteria, and 
viruses as etiological agents (Thomson, !'!tal., 1975). Nevertheless, 
this disease complex is most often associated with pathogenic strains of 
Pasteurella haemolytica biotype A serotype 1 (Jubb, Kennedy and Palmer, 
1985). 
The characteristic lesions of pneumonic pasteurellosis are fulmi-
nating fibrinous pleuropneumonia with interstitial and alveolar edema, 
interstitial lymphatic thrombosis, fibrinous pleuritis, and alveolar 
wall necrosis. Primarily involved is the anterioventral portion of the 
lung, particularly in the cranial and middle lobes. There may also be 
an associated serofibrinous pericarditis and the presence of a yellow 
pleural effusion (Rehmtulla and Thomson, 1981). Microscopically, large 
numbers of the small, rod-shaped, encapsulated, gram-negative bacterium 
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are present adjacent to compacted debris of inflammatory ce 11 s (Jubb, 
Kennedy and Pa l'ller, 1,985; Jensen and Mackey, 1979). The locally 
released bacterial endotoxin and cytotoxin (leukotoxin) as well as the 
capillary thrombosis are thought to cause the characteristic coagulation 
necrosis associated with the pneumonic 1 es ions (Jubb, Kennedy and 
Palmer, 1985). The alveoli are usually filled with fibrin, macrophages, 
and neutrophi 1 s. Lesions from experimentally-induced disease are 
similar to those present in the natural disease (Rehmtulla and Thomson, 
1981). 
Pasteurella haemolytica is frequently present in the upper respira-
tory tract of healthy animals. The lungs are probably exposed to a 
small number of bacteria during normal breathing (Hamdy and Trappy, 
1967; Thompson and Gilka, 1974). Thomson, Benson and Savan (1969) 
reported that high accumulations of bacteria, ~ haemolytica in particu-
lar, in the nasal passages eventually resulted in substantial lung 
exposure and subsequent pneumonia. They also found that ~ haemolytica 
was in higher concentrations in the nasal flora of sick animals compared 
to well animals. This indicated that the bacteria proliferated greater 
1.n the sick animal, thereby allowing for greater opportunity to gain 
access to the lungs (Thomson, et al., 1975). Slocombe, Derksen and 
Robinson (1984b) found that deep breathing after cold exposure may 
increase the number of aerosol particles and enhance depositions of 
these particles in the lung parenchyma. 
The experiments of Slocombe, et al. (1984a) revealed that one hour 
after exposure to!'_:_ haemolytica there was a decrease in the arterial 
oxygen tension. This hypoxia was thought to be due to a ventilation 
perfusion 'llismatch or a diffusion impairment resulting in the persistent 
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perfusion of poorly ventilated pneumonic regions of the lung. The 
hypoxia of the pulmonary tissue was found to continue and by 12 hours 
postinfection there was an increase in pulmonary resistance resulting 
from obstruction of peripheral airways with purulent exudate and ede-na. 
This increase in resistance was also accompanied by extensive areas of 
atelectasis, exudative pneumonia, and obstructive suppurative bronchio-
litis. 
The role of other contributing factors in the pathogenesis of the 
disease is unclear. Following viral infection, the normal pulmonary 
defense mechanisms are compromised or destroyed (Dyer, 1982). Included 
in these mechanisms is the mucociliary, apparatus and intrapulmonary 
phagocytic defenses. Viral infections have been shown to markedly 
impair the clearance of inhaled bacteria if viral infection occurs one 
to two weeks prior to shipment of the cattle (Thompson and Gilka, 1974). 
Viral agents have disrupted the mucous flow out of the lung as well as 
the bactericidal activity of alveolar macrophages (Allan and 'Msolla, 
1980; Jakob, 1981 ). Parainfl uenza-3 virus, in fee tious bovine rhino-
tracheitis, and bovine virus diarrhea have been shown to destroy the 
pu l'llonary macrophage (Rossi and Kiese 1, 1977). These viruses clearly 
can inhibit the normal protective mechanisms of the lung, yet, no direct 
cause and effect relationship was found between the parainfluenza-3 
virus (PI 3) and!:_ haemolytica pneumonia (Thomson, Benson and Savan, 
1969). Houghton and Gourlay (1983) reported a synergistic effect between 
~ haemolytica and ~ycoplasma bovis in producing pneumonia in gnotobio-
tic calves. While simultaneous intranasal or intratracheal innoculation 
of ~. bovis and 18-hour cultures of!.=_ haemolytica did not induce severe 
disease or extensive pneumonic consolidation, the combination of M. 
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bovis and a 6-hour culture of~ haemolytica did increase the severity 
of illness and pulmonary lesions. The most severe disease was produced 
by intranasal and intratracheal inoculation of 6-hour cultures of P. 
haemolytica one day after intranasal inoculation with M. bovis (Gourlay 
and Houghton, 1985). 
Although alveolar macrophages appear to be inefficient in phagocy-
tizing and killing of~haemolytica, they are able to control small 
numbers of the organism. Once the organisms are present in large 
num?ers, the bacteria may be able to further impair macrophage phagocy-
tosis through the production of leukotoxin (Markham and Wi 1 kie, 1980; 
Shewen and T.Yilkie, 1982). ~aheswaran, et al. (1980) determined that P. 
haemolytica, in the presence of opsonins found in normal serum of adult 
cattle or antiserum, are avidly phagocytized by alveolar macrophages. 
Furthermore, heat stable opsonins (antibodies) seem to be more important 
than heat labile opsonins (complement) in the phagocytosis of P. haemo-
lytica. 
Both live~ haemolytica and culture supernatant are toxic to 
alveolar macrophages (Markham and Wilkie, 1980; Benson, Thomson and 
V a 1 1 i , 1 9 7 8 ; Ka e h 1 e r , e t a 1. , 1 9 8 0 b; She wen and W i 1 k i e , 1 9 8 2 ) . C e 1 1 -
free culture supernatant impairs phagocytosis at low concentrations and 
is lethal for bovine leukocytes at higher concentrations. Cytotoxicity 
was related to the number of cells taken up by the macrophage (Markham 
and Wilkie, 1980). Wilkie (1982) suggested that high opsonizing 
antibody responses may not only enhance the phagocytosis of the organism 
but also enhance cytotoxic effects on the alveolar macrophages. Sterile 
culture supernatants of~ haemolytica caused inhibition of the luminal 
dependent chemiluminescence (LDCL) assay response of phagocytically 
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stimulated neutrophil preparations from ruminants but not from nonrumi-
nants. The LDCL response was higher for opsonized than nonopsonized 
bacteria and remained increased longer for opsonized bacteria (Chang, et 
al., 1986a). Yet, with the presence of opsonizing antibody, phagocytosis 
and degradation of most bacteria by alveolar macrophages did not prevent 
the cytotoxic effects on the alveolar macrophages (Maheswaran, et al., 
1980). 
The leukotoxin, present in culture supernatants, is a heat-labile 
exotoxin. Optimum leukotoxic production occurs during the logarithmic 
growth phase (Baluyut et al., 1981; Kaehler, et al., 1980b; Chang, 
Renshaw and Richards, 1986b; Berggren, et al., 1981). It is oxygen 
stable, susceptible to pH extremes, and kills bovine neutrophile and 
mononuclear leukocytes. It is inactivated by trypsin, contains no 
detectable endotoxin, and contains carbohydra~e and protein moieties 
(Baluyut, et al., 1981; Kaehler, et al., 1980b; Chang, et al., 1986b). 
The leukotoxin is nontoxic to equine, fe 1 ine, rabbit, canine, porcine, 
and human blood lymphocytes or bovine erythrocytes, bovine kidney cell 
cultures, or bovine primary spleen cell cultures (Lo, et al., 1985; 
Chang, et al., 1986a; Kaehler, et al., 1980a). 
Leukotoxin neutralizing activity has been demonstrated with bovine 
IgG2 purified from pooled seropositive sera (Cho, et al., 1984). Bovine 
IgG2 is the predominant immunoglobulin in the bovine lung and the 
neutralizating antibody may be a protective immunological response that 
occurs in pneumonic pasteurellosis (Cho, et al., 1984; 3utler, 1981; 
Gentry, et al., 1985). The antigen specificity of the antibody poten-
tial! y plays an important role in protection against the disease. It 
has been postulated, though not proven, that the IgG class of 
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antisomatic antibody is potentially hazardous whereas the IgG class of 
antitoxic antibody may benefit in the prevention of fibrinous pneumonia 
(Cho, et al., 1984). 
Capsular somatic antigen preparations have been extracted from P. 
haemo lytica using potassium thiocyanate, sodium salicylate, and sodi urn 
chloride. Immunization with those extracts enhanced resistance of cattle 
and lambs against experimental challenge with the bacterium (McKinney, 
et al., 1985; Gilmour, et al., 1983; Yates, et al., 1983). Corstvet, et 
al. (1982) demonstrated the ce 11-as soc iated capsular rna teria 1 is pro-
duced in greatest quantity during the early logarithmic growth phase 
corresponding to 2-6 hour of culture growth. Cell-associated capsular 
material diminished with culture age. Organisms from cultures 16 hours 
old or greater were found to have little capsular material remaining on 
the orgam.sm. Ad lam, et al. (1984) found that capsular polysaccharide 
had two component sugars (2-acetamido-2-deoxymannopyranose and 2-aceta-
mido-2-deoxymannosyranosyluronic acid) localized on the periphery of 
the bacterial cell wall. The purified polysaccharide was found to be 
specific to the A1 serotype of ~ haemolytica, immunogenic to sheep but 
not rabbits, and periodate treatment did not significantly alter its 
precipitability with immune serum. Antiserum to the purified polymer 
reacted with sodium salicylate and sodiQm chloride extracts of P. haemo-
lytica. ~cKinney, et al. (1985) purified saline extracted capsular 
material using preparative isoelectrofocusing. The extract contained 
proteins ranging from 33 kDa to greater than 80 kDa. Calves vaccinated 
with this extract had greater resistance to experimental pneumonic 
pasteurellosis than did nonvaccinated calves. Later, Less 1 ey, et al. 
(1985) purified saline extracted capsular antigens using 
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chromatofocusing. Six antigenic fractions were collected and identified 
as glycoproteins. One of the fractions contained lipopolysaccharide. 
These antigenic fractions were found to cross react with the antigenic 
fractions isolated e•rlier by McKinney, et al. (1985). 
The lipopolysaccharide fr~ the organism has been isolated (Confer 
and Simons, 1986; Brogden, et al.,, 1986) and was evaluated with respect 
to effect on bovine leukocytes. It was found to be non-toxic to poly-
morphonuclear leukocytes, increased the migration of peripheral blood 
leukocytes, and was blastogenic to bovine lymphocytes in moderate 
concentrations while suppressive in high concentrations. Antibodies to 
lipopolysaccharide did not correlate with protection against experi-
mental bovine pneumonic pasteurellosis. 
Two major outer membrane proteins (30 kDa and 42 kDa) have been 
isolated by Squire, Smiley and Croskell (1984). Because these proteins 
are involved in transport mechanisms and adhesion to host cells, anti-
bodies to these proteins have been suggested to kill these organisms 
through inhibition of protein function. Antigenicity of these proteins 
was not determined in these studies. 
Following vaccination with P. haemolytica bacterins, not only 
were cattle not protected against experimental pneumonic pasteurellosis 
or from natural disease (Martin, 1983; Confer, et al., 1985a), but 
enhancement of experimental and natural disease has been shown to occur 
(Friend, et al., 1977; Wilkie, Markham, and Shewen, 1980). Panciera, et 
al. (1984) recently induced antibody titers to somatic antigens by 
vaccinating with live Pasteurella sp. Calves vaccinated with 6-hour 
cultures showed greater resistance to the challenge exposure than those 
innoculated with 20-hour cultures (Confer, et al., 1984). There was a 
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correlation between high antibody titer and low pulmonary lesion scores 
regard less of the age of culture used as the immunogen (Panciera, et 
al., 1984; Confer, et al., 1984). 
Many antigenic preparations, as discussed above, have been isolated 
in an attempt to study the immunological significance and the importance 
of such antigens in the protection from pneumonic pasteurellosis. 
A technology currently used in an attempt to uncover the co'llplex 
pathogenesis in many disease processes is the production of mononclonal 
antibody (Mab) hybridomas. Monoclonal antibodies have been used as 
probes for fine structure of proteins, histocompatibility, tumor local-
ization and classification, purification of molecules by affinity 
chromatography, and identification of previously undefined antigens on 
the surface of lymphocytes (Goding, 1980). 
llybridomas are the result of fusion of antigenically stimulated 
lymphocytes with myeloma cell lines. The rationale behind cell fusion 
is covered in various literature reviews (Goding, 1980; Paul, 1984). 
It is based on the formation of heterokaryons as a result of fusion of 
the plasma membranes. At the next cell division, a hybrid cell results. 
After repeated cloning and passage, a hybrid cell line is developed and 
these are referred to as hybridomas. 
Several procedures are required to allow for the replication of 
these hybrid cells. Aminopterin, a folic acid antagonist, blocks the 
main biosynthetic pathways for purines and pyrimidines. Mammalian cells 
have salvage pathways in which preformed nucleotides are recycled. 
These salvage pathways depend on thymidine kinase (TK) and hypoxanthine 
guanine phosphoribosyl transferase (l!GPRT). If the cell is provided with 
thymidine and hypoxanthine and the enzymes TK and HGPRT are present, DNA 
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synthesis can still occur. If spleen cells process~ng TK and qGPRT are 
fused with myeloma cells lacking TK and HGPRT, only the hybrid will grow 
in media containing hypoxanthine, aminopterin, and thymidine. 
The myeloma cell lines currently used for hybridoma production vary 
in several characteristics. Many of the early cell lines had the capac-
ity to continually synthesize and secrete sets of both light and heavy 
immunoglobulin chains from the fusion partners. Recently a variety of 
genetic defects resulting in failure of immunoglobulin production or 
secretion by the myeloma cell line have been described (Wallach, et al., 
1982). The X63-A.g.8.653 has irreversibly lost the ability to express Y1 
or K chains (Kearney, et al., 1979). This line is a subclone of the 
mouse myeloma cell line P3-X63-A.g8 and is derived from the original HAT 
sensitive myeloma cell line variant of ~10PC-21. 110PC-21 is the cell line 
in which Cotton and Milstein (Kearney, 1984) first constructed a contin-
uous antibody secreting cell line. The serum of myeloma or hybridoma-
bearing mice contain large amounts of homogeneous antibodies. The 
advantages of having a cell line such as X63-A.g.8.653 is that of obtain-
ing a high fusion frequency and a large number of hybridomas producing 
only the specific antibody of the desired antigen stimulated spleen 
cells (Kearney, et al., 1979). 
Screening the hybridomas for specific antibody production is time 
consuming and laborious because it ~s frequently performed on many 
preparations. The screening procedures used should be simple, rapid, 
convenient, and environmentally safe (Paul, 1984). Other considerations 
inc 1 ude the ultimate use of the monoclonal and the 1 imitations of the 
screening technique with respect to the antigen used. 
There are frequently used procedures for screening hybridomas for 
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specific antibody production such as solid-phase radioimmunossay, 
enzyme-liked immunosorbent assay (ELISA), immunoflorescence, cytotox-
icity assays, rosetting assays, assays to inhibition of activity, and 
polyacrylamide electrophoresis with Western immunoblotting. Western 
blotting, also called protein blotting, is reviewed by Towbin and Gordon 
(1984). It is based on the transferring proteins from gel electrophoro-
grams to a solid phase which allows the access of information regarding 
the immunoreactions to the antigen in question. Diffusional transfer of 
proteins to nitrocellulose was reported by Renart, Reiser, and Stark 
(1979), followed by Towbin, Staehelin and Gordon (1979) ~n which 
proteins were transferred in an electric field with noncovalent binding 
to nitrocellulose. Once the desired antigen is blotted onto a solid-
phase nitrocellulose sheet, it may be reacted with immunoglobulin to 
determine the specific protein in question. Several detection systems 
are used to identify reactive proteins, of which peroxidase is the most 
widely used enzyme label. 1fuether or not desired sensitivity can be 
achieved with blotted proteins depends on the degree of antigen renatur-
ation, suppression of background staining, and sufficient concentration, 
affinity, and incubation times of the immune reagents (Towbin and 
Gordon, 1984). 
Once hybridomas are replfcating in cell culture and found to be 
secreting antibodies, the cells must be cloned to assure that the 
antibody produced is a monoclonal antibody, i.e., derived from one cell. 
There are three methods of cloning hybridoma cells. Soft agar cloning 
uses two layers of agar, a firm underlayer and a second soft agar layer 
containing the cells to be cloned (Goding, 198'3). The method of 
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limiting dilution is such that growth follows the Poisson distribution 
expressed by the equation 
].lA e-].1 
].1 
(Lefkovits and T.Valdmann, 1979). The dilutions are made serially to 
achieve a statistical probability of having only one cell per well 
(Snedecor and Cochran, 1980). The third cloning method is one in which 
the Fluorescence-activated Cell Sorter (F~CS) is used (Parks, Bryanum 
and Herzenberg, 1979). Although the equipment is expensive, the main 
advantage is it allows for selection of cells of desired antigen-binding 
specificity (Goding, 1983). Once the desired hybrido~a has been 
selected and cloned, large scale production, purification, and charac-
terization of the monoclonal antibody may proceed. 
Monoclonal antibodies can potentially further the purification and 
characterization of !:._ haemo 1 yt ica antigenic preparations av ai 1 ab 1 e 
today and allow for the isolation of antigenic determinants to the 
organ~sm. As new tools of techniques become available, so come the 
opportunities of unraveling the complex pathogenesis in disease entities 
such as Bovine Pneumonic Pasteurellosis. The purpose of the studies 
described herein were to attempt the production of a monoclonal antibody 
to the leukotoxin of P. haemolytica. 
CHAPTER III 
MATE~IALS AND METqQDS 
Microorganism 
The Pasteurella haemolytica biotype A serotype 1 used in these 
experiments were originally isolated from the trachea of a feedlot calf 
(Corstvet, et al, 1973). Cultures were grown on either brain-heart 
infusion agar (BHI) or enriched BHI agar at 37°C, The cultures were 
used directly or resuspended in BHI broth or in RPMI 1640 tissue culture 
medium (Gibco, Grand Island, New York) depending on the intended use, as 
described be low. 
Pasteurella Leukotoxin Immunizing 
Antigen Preparation 
The preparation of the semicrude leukotoxin antigen and the 
partially purified cytotoxic preparation were as described by Mosier, et 
al. (1986). 
Antigen Screening Preparations 
Lactoferrin Cytotoxin 
Leukotoxin was prepared using lactoferrin as the protein source in 




Leukotoxin was produced as described by Baluyut, et al. (1981). 
Lyophilized ~ haemolytica was grown on enriched BHI agar plates for 18 
hours. Fifteen colonies were placed in 100 ml of BHI broth in 250 ml 
flasks and grown for 6 hours at 3rc. The ce 11 sus pens ions were 
centrifuged at 13,500 x gin a Sorvall Superspeed RC2-B centrifuge 
(DuPont, Wilmington, Delware) for 30 minutes at l0°C. The cell pellet 
was resuspended in 200 ml of RP'1I 1640 medium and placed in a 500 ml 
flask and incubated at 37°C for four hours in a Lab-LineR incubator-
shaker (Lab-Line Instruments, Melrose Park, Illinois). Afterwards, the 
suspensions were centrifuged, as above, and the supernatants sterilized 
by passage through consecutive 0.45 urn and 0.22 urn Nalgene filters. The 
supernatants were concentrated in dialysis tubing (>8,000 mw exclusion) 
using Aquacide II-A (Calbiochem, San Diego, California). The leukotoxin 
supernatants were dialyzed in 0.05 M phosphate buffered saline (PBS) (pH 
7. 2). The protein concentration was determined by a dye-binding method 
using commercially prepared reagents (Bio-Rad Laboratories, Richmond, 
California) and found to be 11 ug/ml. 
Six-Hour Sonicated Antigen 
Lyophilized ~ haemolytica was reconstituted in 1 ml sterile 
distilled water and grown on BHI agar plates for 18 hours. Fifteen 
colonies were placed in 100 ml of RP~I 1640 medium in a 250 ml flask and 
grown at 37°C in a Lab-LineR incubator-shaker. Cell growth was allowed 
to occur for 6 hours. The cells were centrifuged at 13,500 x g for 30 
minutes in the Sorvall centrifuge. The cells were washed three times in 
cold PBS and resuspended in 30 ml of 0.5 M PBS. The cell suspensions 
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were sonicated on ice with the SonifierR Model 200 (Branson Sonic Power 
Company) at maxi~um power for 60 seconds and then centrifuged for 1~ 
minutes in an Eppendorf Microcentrifuge. 
Six-Hour Sodium-Dodecyl Sulfate Antigen 
Lyophilized ~ haemolytica were resuspended in 1 ml sterile 
distilled water and grown on BHI agar plates for 18 hours. Fifteen 
colonies were grown in 250 ml of RP~I 1640 medium in 250 ml flasks at 
3rc in a Lab-Line incubator-shaker for 6 hours. The ce 11 sus pens ions 
were centrifuged at 13,500 x g for 30 minutes in the Sorv all centrifuge. 
The cells were washed three times in cold PBS and resuspended in 30 mls 
of 5% sodium-docecyl sulfate (SDS). 
Saline-Extract Antigen 
The ~ haemolytica saline extract antigen, rich in capsular poly-
saccharide, was that described by Lessley, et al. (1985). 
Outer Membrane Proteins 
Outer membrane protein antigens of~ haemolytica were provided and 
described by Squire, Smiley and Croske 11 (1984). 
Antisera 
Six to eight week old, female, BALB/C mice were immunized intra-
peritoneally with a 50 ug per mouse dosage of the semicrude leukotoxin 
preparation in 0.01 ml of Freund's complete adjuvant followed by three 
weekly 50 ug doses in 0.01 ml of Freund's incomplete adjuvant. The mice 
were boosted intraperitonea lly every 4 to 6 weeks with a 1:1 ratio of 
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Freund's incomplete adjuvant and a 50 ug per mouse dose of ~ partially-
purified cytotoxin preparation. The mice were periodically bled from 
the tail vein. The blood was pooled, allowed to clot, and then centri-
fuged for 10 minutes in an Eppendorf centrifuge. The serum was removed 
and stored at -70°C. 
Negative control sera was collected similarly from pooled blood 
samples obtained from age and sex-matched BALB/C control mice. 
Enzyme-Linked Immunosorbent Assay 
The enzyme-1 inked immunosorbent assay (ELISA) was used to screen 
the hybridoma cells as described by Voller, Bidwell and Bartlet (1979). 
All antigen preparations were diluted in carbonate-bicarbonate buffer 
(pH 9.6). Preparations of 1 ug/ml or 10 ug/ml of antigen were placed on 
Immulon II plates (Dynatech Laboratories, Alexandria, Virginia) at 50 ul 
per well and allowed to coat overnight at 4°C. Control serum dilutions 
of 1:100 were prepared in 0.05 "":1 PBS containing 0.05% Tween 20 solution 
(PBS-Tween 20 solution) and 1% bovine serum albumin (BSA) or 1% 
ovalbumin. Volumes of 50 ul of serum or hybridoma culture supernatants 
were allowed to incubate for 1 or 2 hours. Plates were washed five times 
with PBS-Tween 20 solution. Alkaline phosphatase-conjugated goat anti-
mouse polyvalent whole molecule antibody (Sigma Chemical Company, St. 
Louis, 'fissouri) was mixed with PBS-Tween 20 solution and 1% ovalbumin 
at a dilution of 1:200 and allowed to incubate for 1 to 2 hours. The 
plates were washed five times with PBS-Tween 20 solution. The substrate, 
containing p-nitrophenyl phosphate in diethanolamine buffer, was added 
to the plate and allowed to incubate. After 30 minutes, the reaction was 
stopped by the addition of 50 ul of 3N sodium hydroxide per well. The 
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optical density of the plates was read at 40S nm (on405 ) in a Bio-Tek 
EIA reader Model EL307 (Bio-Tek Instruments Inc., Burlington, Ver~ont). 
Evaluation of the Immunologic Schedule 
To determine the optimal immunization dosage and schedule, murine 
splenic mononuclear leukocytes were isolated and the lymphocytic blasto-
genic response to various P. haemolytica antigen preparations was 
evaluated. In a method adapted from Baldwin, Antczak and Winter (1985), 
12 mice, divided into 6 groups of 2 mice per group, were intraperitone-
ally injected with crude, semicrude, or a partially-purified leukotoxin 
in doses of SO and 100 ug per mouse or 200 and 400 ug per mouse. The 
immunization schedule was similar to that described by Stahli, et al. 
(1980). The partially-purified antigen preparation was injected at 
weekly intervals for four consecutive weeks. Five days before recovering 
the lymphocytes, the mice were injected with either SO or 200 ug of one 
of the three antigen preparations. For the next four days, the mice 
received 100 or 400 ug, respectively, of the same antigen previously 
injected. Serum was collected and the antibody response to the 
partially-purified antigen was determined by the ELISA. Sub sequent 1 y, 
each mouse was killed by cervical dislocation and spleens were aseptic-
ally recovered and minced with a glass tissue homogenizer. The splenic 
mononuclear leukocytes were recovered by underlaying the spleen 
suspension with Ficoll-paque (Pharmacia Fine Chemicals, Piscataway, New 
Jersey) followed by centrifugation at 800 x g for 20 minutes at 20°C. 
The cells obtained from the Ficoll-plasma interface were washed three 
times in PBS, centrifuged at 7QO x g for 10 minutes and were resuspended 
in 1.1 ml of RP\fl 1640 medium containing 0.1% gentamycin. The cells 
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were counted and adjusted to a concentration of 2 x 106 cells/ml in RP~I 
1640 medium. RP~I 1640 medium containing 0.1% gentamycin and 20% fetal 
bovine serum (FBS) was placed in a 96-well microtiter plate (Costar, 
Cambridge, ~assachusetts) at 100 ul per well. ~n equal volume of each 
cell suspension was added to wells in the plate at 100 ul/well. H 1 
assays were carried out in duplicates. After a 3 day incubation at 37°C 
in a humid 5% co2 atmosphere, 20 ul of a 1:25 dilution of 3H-Thymidine 
was added to each well. Eighteen hours after labeling, the cells were 
harvested on filter paper using a semiautomatic cell harvester (Skatron, 
Lier, Norway). The filter papers were dried for 2 hours at 50°C and 
added to a toluene-base scintillation cocktail (PPO-Bis ~SB, ICN Biomed-
icals, Irvine, California). Counts per minute (CP~) were determined in a 
Packard Tri-CarbR 300 refrigerated scintillation counter (Packard, 
Downers Grove, Illinois). The average of each group was taken and a 
stimulation index (SI) calculated: 
SI = Avg CPM for cells from injected mice 
Avg CPM for cells from control mice 
Murine Monoclonal Antibody Production 
Monoclonal antibodies were produced as described by Goding (1983) 
and Cunningham and Russell (1983). Six to eight week old, female, 
BALB/C mice were immunized intraperitoneally four times at weekly 
intervals with 0.02 ml of a emulsion containing equal volumes of 
Freund's incomplete adjuvant and 50 ug of a semicrude leukotoxin. Five 
days before fusion, the mice were injected intraperitoneally with 200 ug 
of a partially-purified cytotoxin preparation in sterile PBS. T:1is was 
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followed by an injection of 400 ug of the same preparation for the next 
four days. 
The mice were killed by cervical dis location. Spleens were asep-
tically removed and minced through a sterile 100-mesh screen. The 
spleen cells were rinsed in Iscove's 'iodified Dulbecco medium (D1DM) 
(Gibco) containing 0.1% gentamycin and pelleted by centrifugation at 400 
x g for 7 minutes. The cells were resuspended in 10 ml of I'1DM contain-
ing 0.1% gentamycin. 
Murine myeloma cells (x63-Ag8.6.5.3) were counted, mixed at a 1:1 
ratio with the suspended spleen cells, and pelleted by centrifugation at 
400 x g for 7 minutes. The supernatant was decanted and 3 ml of 35% 
sterile polyethylene glycol (pH 8.5) was added. The pellet was centri-
fuged at 400 x g for 2 minutes at 25°C, then allowed to remain 
undisturbed for 6 minutes at 30°C. To stop the fusion reaction, 40 rnls 
of IMDM and 0.1% gentamycin were added to the cells. The cells were 
centrifuged at 400 x g for 8 minutes and the supernatant discarded. The 
cells were placed in 40 ml of I'1DM containing 20% FBS (Hyclone, Logan, 
Utah) in 75 cm2 flasks, and incubated overnight at 37°C and 8% co2• The 
following day, cells were placed into wells of 96-well microtiter plates 
(Nunc, Hazelton Research Products, Denver, Pennsylvania) at 200 per 
we 11. Fresh P1DM containing 0.1% gentamyc in, 20% FBS, 5 x 1 o-3 ~1 hypo-
xanthine, 2 x 10-5 M aminopterin, and 8 x 10-4 l1 thymidine was used to 
replace spent medium every other day for two weeks. At the end of two 
weeks, medium was replaced with IMDM containing 0.1% gentamycin, 20% 
FBS, 5 x 1~-3 M hypoxanthine, and 8 x 10-4 M thymidine. During that 
ti'Ile, all acidic culture fluids were tested for antibody to the cyto-
toxin preparations by the ELISA method. 
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Hybridoma cells in positive wells in 96-well plates were 
resuspended in 2.0 ml volu;nes in 24-well plates (Nunc). When cells 
became confluent, the culture fluids were tested by the ELISA and the 
cells were frozen in IMD~ containing 0.1% gentamycin, 10% DMSO, and 20% 
FBS. The cells were cloned three times by limiting dilution at 0 to 4 
cells per well. Each time the cells were cloned, they were regrown in 
24-well plates and frozen. The limiting dilution method of cloning is 
one in Which follows the Poisson distribution, thereby allowing a method 
of obtaining a reasonable probability that wells which show growth 
contain single clones (Goding, 1980). All cloning was carried out at 
least two dilutions that were ten fold. During the cloning, all positive 
wells subsequently used were ones giving the greatest probability of 
having a single clone per well. The probability of the hybridomas being 
monoclonal was calculated using information from Lietzke and Unsicker 
(1985). 
Polyacrylamide Gel Electrophoresis and 
Immunoblot Techniques 
Discontinuous sodium-dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PA.GE), as described by Laemmli (1970) with some modifica-
tions, was used to differentiate the protein bands of the various 
antigen preparations. Antigen preparations were boiled for 90 seconds 
in 0.125 M Tris-Cl (pH 6.8), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol 
and bromophenol blue. Molecular weight marker proteins (Sigma Chemical 
Company), diluted 1:20, were used as standards on each gel. 
rnirty ul of a prepared sample antigen were added to each well in a 
4% acrylamide stacking gel containing 0.125 m Tris-Cl (pH 6.8) and 0.1% 
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SDS. This overlayed a 10% acrylamide resolving gel containing 0.375 1\f 
Tris-Gl (pH 8.8) and 0.1% SDS. The electrode buffer consisted of 0.025 1\f 
Tris (pH 8.3), 0.192 M glycine, and 0.1% SDS. Electrophoresis was 
conducted using a Mighty Small minature slab gel electrophoresis unit 
(SE200, Hoefer Scientific Instruments, San Francisco, California) at a 
constant current of 35 rnA for 1.5 to 2 hours. Immunoblotting was 
performed as describe~ by Towbin, Staehelin and Gordon (1979), with 
modifications described by Nielsen, et al. (1982). The gel was removed 
from the electrophoresis unit and washed three times for 10 minutes each 
in transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol, and 0.01% 
SDS, pH 8.3). The protein transfer from the gel onto nitrocellulose 
paper was done using the Mini Transphor (TE22, Hoefer Scientific Instru-
ments) at a constant current of 250 rnA for 1.5 hours. A portion of the 
nitrocellulose paper was stained with a mixture of 0.1% amido blac~ lOB 
(BioRad Laboratories, Richmond, California), 45% methanol, and 10% 
acetic acid for 3 minutes and destained for 20 minutes in a mixture of 
SO% methanol, 3.5% acetic acid, and 16% distilled water. The remainder 
of the blot was quenched with 3% ovalbumin (Sigma Chemical Company) in 
PBS-0.05% Tween 20 solution for one hour at 37°C. The membrane was 
washed five times at 5 minute durations with PBS (pH 7.5) containing 
PBS-0.1% Tween 20 solution. The membrane was cut into strips and 
incubated overnight at room temperature with antisera controls or mono-
clonal antibody supernatant. The strips were washed five times at 5 
minute durations with PBS-0.1% Tween 20 solution. Strips incubated with 
mouse serum or culture supernatant were further incubated with biotin-
ylated anti-mouse species specific whole immunoglobulin molecule, 
~vhereas strips incubated with rabbit or bovine sera were incubated with 
23 
biotinylated Protein A (Amersham, Arlington Heights, Illinois). The 
biotinylated compounds were diluted 1:300 in PBS-Tween 20 solution 
containing 1:300 in 1% ovalbumin. Incubation was for 1 hour at room 
temperature followed by five washes in PBS-Q,1% Tween 20 solution. Each 
nitrocellulose strip was then incubated with a 1:400 dilution of 
streptavidin-biotinylated enzyme preformed complex in 1% ovalbumin for 
30 minutes. Antigenic bands were seen after incubation for 10 - 15 
minutes in a mixture of 0.5 mg/ml 4-chloro-1-naphthol in PBS containing 
0.03% 1120 2• Blots were rinsed in P'BS and allowed to air dry. 
Detection of Carbohydrate Epitopes Using 
Periodate Oxidation 
The method described by Woodward, Young and Bloodgood (1985) w·as 
modified slightly and used to determine if the mononclonal antibody was 
directed against antigenic determinants with a carbohydrate moiety. Two 
Immunlon II (Dynatech Laboratories) 96-we 11 micro titer plates were 
coated overnight at 4°C with 50 ul per well of the partially-purified 
leukotoxin, the 6-hour sonicated antigen, and the capsular extract anti-
gen at 10 ug of protein/ml in carbonate-bicarbonate buffer (pH 9.6). 
After coating, one plate was used as a control, the other was treated 
with sodium m-periodate. The plates were then washed five times with 
PBS-Tween 20 solution and patted dry. The periodate-treated plate was 
flooded two times with 50 mM sodium acetate buffer (pH 4. 5) and patted 
dry. This plate was incubated for 1 hour at room temperature in the 
dark with 10 mM sodium m-periodate in 50 mM sodium acetate buffer (pH 
4.5), then rinsed two times in 50 mM sodium acetate buffer, and patted 
dry. A. 50 mM sodium borohydride so 1 ution in PBS was added to the we 11 s 
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for 30 minutes at 25°C, followed by five washes in PBS-Tween 20 solu-
tion. The assay was completed similarly for both the control and 
periodate-treated microtiter plates. Monoclonal culture supernatant, 
positive control mouse serum, or FBS control media were added to the 96-
well microtiter plate and allowed to incubate for 1 hour. The plates 
were washed five times with PBS-Tween 20 solution. Alkaline phosphatase 
conjugated goat anti-mouse polyvalent whole molecule antibody (Sigma 
Chemical Company), diluted 1:200 in 1% ovalbumin, was added to each well 
and incubated for 1 hour. The plates were washed five times with PBS-
Tween 20 solution. Substrate [p-nitrophenyl phosphate in 10% diethanol-
amine buffer (1 mg/ml)] was added to each well and incubated for 30 
minutes. The enzymatic reaction was stopped by the addition of 50 ul of 
3 N sodium hydroxide per well. The on405 values were determined. 
Determination of Immunoglobulin Isotype 
The monoclonal antibody was subisotyped by the ELISA method using a 
mouse mononclonal subisotyping kit containing rabbit anti-mouse IgG, 
IgG2a, IgG2b, IgG3, IgM, and IgA (Hyc lone Laboratories). 
Quantitation of I~unoglobulin 
The immunoglobulin concentration of the hybridoma supernatants were 
quantified by the method of Schoenfeld, et al. (1983). A.f fini ty 
purified goat anti-mouse IgM (u chain specific) (Cooper Biomedical Inc., 
Malvern, Pennsylvania) was placed in wells a 96-well microtiter Immulon 
II plates at 10 ug/ml diluted in PBS (pl.! 8.5). The plates were incubated 
at 4°C overnight. The plates were washed three times with PBS-Tween 20 
solution. Two-fold dilutions of each monoclonal antibody supernatant 
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and the standard mouse i~munoblobulin (Meloy Laboratories Inc., Spring-
field, Virginia), at ten-fold dilutions, were placed on the respective 
plates. The plates were incubated for 1 hour then washed three times in 
PBS-Tween 20 solution. Alkaline phosphatase goat anti-mouse polyvalent 
antiserum was incubated at a 1:200 dilution at 4°C overnight. A color 
reaction was quantitated as described above. Concentrations of IgM 
present in the supernatants were calculated from standard curves 
constructed of the reaction of the immunoglobulin standards. 
Indirect Fluorescent Staining of 
Various Bacteria 
Pasteurella haemolytica A1, Pseudomonas aeroginosa, Pas teure 11 a 
multocida, Hemophilus influenza, Klebsiella pneumoniae, and Escherichia 
coli were grown for 18 hours on enriched BHI agar plates. Each culture 
was removed from the plate with a cotton swab and emulsified in PBS. 
The cells were washed three times in PBS and centrifuged at 800 x g for 
10 minutes. Cells were reconstituted to 0.5 :1cFarland standard and 20 
ul of each cell suspension was placed on a clear glass microscope slide. 
The slides were air dried then fixed in acetone for 10 minutes. Slides 
containing each bacterium were covered with the mononclonal antibody 
supernatant or I:1DM with 15% FBS negative control and placed in a humid-
ified chamber at 3rc for 1 hour. All slides were washed five times in 
PBS with agitation at 5 minute intervals. A 1:5 dilution fluorescein-
conjugated goat anti -mouse IgM immunoglobulin (Me loy Laboratories Inc., 
Springfield, Virginia) was incubated on the slides at 37°8 for 1 hour. 
The slides were washed five times at 5 minute intervals in PBS and 
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briefly rinsed in distilled water. A coverslip was mounted on each 
slide with glycerol and viewed using a fluorescent microscope. 
51 chromium-Release Assay 
The ability of the monoclonal antibody to neutralize the leukotoxic 
effects of ~ haemolytica were tested by the 51chromium-release assay. 
The leukotoxin was prepared as described by Lo, et al. (1985). Mixed 
peripheral b load leukocytes were collected from heal thy donor calves. 
Leukocytes were separated from the blood by flash 1 ys is of the 
erythrocytes with hypotonic distilled water, resuspensed to isotonicity 
and centrifugation of the cell pellet. The cells were washed twice with 
physiologic PBS and resuspended to a final concentration of 1 x 107 
cells/ml in RP':-II 1640 medium. The cells were labeled with 50 uCi of Na 2 
[51cr] o4 (ICN Pharmaceuticals Inc., Irvine, California) per ml of 
ce 11 s. The ce 11 s were incubated for 1 hour at 37°C in a shaker bath. 
The cells were washed three times with PBS, resuspended in RPMI 1640 
medium, recounted, and the final concentration was determined to be 6.9 
x 1Q6 cells/ml. 
The monoclonal supernatant immunoglobulin and FBS-I~DM negative 
control culture fluid were precipitated with 50% ammonium sulfate. The 
precipitates were centrifuged at 800 x g for 15 minutes at 0°C. The 
retrieved pellets were resuspended in 5 ml of PBS and dialyzed in 
dialysis tubing (>8,000 mw exclusion) in PBS. The undiluted precipi-
tated mononclonal antibody and FBS-I-:vtDM negative control were added 
directly to 96-well tissue culture plates (Corning Glass \-lorks, Corning, 
New York). Likewise, 60 ul of each RPMI 1640 medium, PBS, Naoa, or 
hyperimmune bovine serum were added directly to the plate as test 
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controls. Leukotoxin dilutions (1:4, 1:16; 1:64) in the amount of 120 ul 
was added to the corresponding wells. The plate was allowed to incubate 
for 10 minutes at room temperature. The addition of 9 0 u 1 per we 11 of 
51 cr labelled cells were placed in the microtiter wells and the plate 
was incubated for 1 hour at 3rc in 5% co 2. The plate was centrifuged 
for 10 minutes at 200 x g, after which 150 ul of supernatant was trans-
ferred to a plastic test tube for counting in an automated gamma counter 
(Searle Analytical Co.). Counts per minute (CP~1) were determined and 
percent killed was calculated: 
% Killing = Avg CPM test sample- Avg CPM of PBS negative control x 100 
C~ positive control - CPM of RPMI negative control 
Electron Microscopic Analysis 
Lyophilized~ haemolytica were reconstituted in 1 ml sterile 
distilled water and grown on BHI agar plates for 18 hours. Fifteen 
colonies were placed in 100 ml of RPMI 1640 medium in a 250 ml flask and 
grown at 37°C for 6 hours. The cells were centrifuged at 800 x g for 15 
minutes. The cells were washed in 1 ml of 1%-PBS and centrifuged in an 
Eppendorf microcentrifuge for 2 minutes. They were then washed three 
times in PBS. The cells were resuspended in 500 ul of Mab Ell in 
culture supernatant or IMDM with 15% FBS and allowed to incubate for 15 
minutes at 37°C. The cells were microcentrifuged for 2 minutes and 
washed three times in 0.05% PBS-Tween 20 solution. A 1:5 dilution of 
goat anti-mouse IgM was conjugated with colloidal gold (Jansen, Belgium 
Ger:nany) and incubated for 15 minutes at 3rc. The cells were micro-
centrifuged for 2 minutes and washed three times in 0.05% PBS-Tween 20 
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solution. The cells were resuspended in 500 ul of PBS and placed on 
nitrocellulose coated carbon-copper grids. A 1% solution of neutralizing 
phosphotunstic acid was used to coat the bacterial coated grids. The 
grids were read using a Hitachi transmission electron microscope. 
CHAPTER IV 
RESULTS 
Evaluation of the Immunization Schedule 
The mean stimulation index for the two mice immunized with various 
Pasteurella antigen preparations in each of the six groups was 8 to 18 
times greater than that of the unimmunized control mice. Because of the 
large variation of individuals within groups using tritiated thymidine 
incorporation, the differences among the groups were not thought to be 
of practical consideration. The on405 of the ELISA, measuring antibody 
production to the partially-purified leukotoxin, was found to vary 
approxi~ately 0.208 between the high and low value. These data suggest 
that although the vaccination schedule tested produced a large increase 
in the stimulation index over the negative control mice, there was no 
practical significance in whether the mice received the more pure or the 
crude leukotoxin preparations. The immunizing preparation, likewise, 
did not produce a noticeable difference in antibody production in the 
individual mice. 
Testing for Antibody Production by Hybridomas 
After fusion of spleen cells to myeloma tumor cells, all wells of 
the 96-well microtiter plate having hybridoma cell growth were screened 
for antibody to the partially-purified leukotoxin preparation (Table I). 
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TABLE I 
RESULTS FROM SCREENING THE INITIA-L 
CELL CULTURE HYBRIDO~AS FROM 
FUSIONS 1 AND 2* 
OD Reading of 
Positive 
Hybridoma No. Hybridoma Mouse Sera Media Control 
2.5 o. 639 1. 370 0.013 
2.31 0.430 1. 370 0.013 
2. 21 0.565 1. 370 0.013 
1. 22 1. 999E 1.410 0.000 
1. 34 0. 651 1. 410 0.000 
2.20 0.350 1. 370 o. 013 
1. 29 o. 246 o. 472 0.008 
2.57 0.177 0.604 0.002 
2. 58 0.146 0.604 0.002 
1.104 1. 999E 1. 999E 0.007 
1.213 1. 999E o. 726 0.024 
1.227 0.547 o. 726 0.024 
1.131 o. 714 o. 844 0.021 
2.106 0.593 0.573 0.019 
1. 183 0.814 1. 031 0.059 
2.350 0.889 1.150 0.021 
*A.ll hybridomas were screened using the ELISA method against the 
partially-purified cytotoxic preparation described by Mosier, et 
al. (1986). Optical densities were read at 405 nm. Optical 
densities at 1. 999 E were equivalent to a reading > 2. 0 at 405 nm. 
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Because of antibody reactions with extraneous protein contaminating that 
antigenic preparation, as determined by preliminary Western i~munoblots, 
hybridoma supernatants listed in Table I and hybridoma supernatants from 
two subsequent fusions were tested for antibodies to a lactoferrin 
leukotoxin (Table II). The final leukotoxin preparation used to screen 
for antibody production was that made with RP~I 1640 medium without 
added protein (RPMI-leukotoxin) due to the reactions to extraneous 
proteins found in the lactoferrin leukocytoxin (Table II). 
TABLE II 
RESULTS FROM SCREENING HYBRIDOMAS WITH A 
LACTOFERRIN-LEUKOTOXIN* 
OD Readings of 
Positive Media Lactoferrin 
Hybridoma No. Hybridoma Mouse Sera Control Control 
4. 6. F6 o. 477 0.525 o. 030 ~** 
1. 213. E12 1. 569 0.525 0.030 1.550 
1.213.D9 1.102 0.525 0.030 1. 835 
1. 213. HZ 0.916 0.525 0.030 1.065 
4.6.D1 0.425 1.999E 0.107 ND 
4.4.Dll 0.216 1. 999E 0.107 ND 
3.8.D8 o. 762 1.999E 0.488 ND 
*Preparation described by Gentry, et al. (1986). Clone numbers contain-
ing 1.213 were retrieved from frozen cell cultures. All others were 
the initial cell culture hybridomas of subsequent fusions. All ELISA 
optical densities were read at 405 nm. 
**ND=Not Done. 
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Figure 1 describes the origin of each of the four monoclonal 
antibodies subsequently characterized. Positive wells were chosen on 
the basis of high optical density readings (Tables I and II) and cloned 
three consecutive times. The probability of any one of the four chosen 
hybridomas being a monoclonal antibody was greater than 97% (Table III). 
Characterization of the Antibody 
After the third cloning, 50 ml volumes of supernatant were produced 
from 1.213 El2H2Ell (Mab Ell), 1.213 Glllill:Bl (\fab 131), 1.22 C23B6G9 
(Mab G9), and 1.104 ClODlOAlO (Mab AlO) for characterization. All mono-
clonal antibody preparations were reacted to various antigen prepara-
tions in the ELISA (Table IV). \fab G9 and Mab AlO appeared to be 
reacting to the extraneous bovine serum proteins present in the 
partially-purified leukotoxin. Mab 131 was unreactive to all of the 
available antigen preparations. \fab Ell appeared to be the only antibody 
reacting to~haemolytica antigens. Because Mab Ell reacted to all 
antigenic preparations, it indicates that a common epitope is present in 
each preparation. 
13y SDS-PAGE, the SDS .£.:_ haemolytica antigen preparation and sonl.-
cated ~ haemolytica antigen preparation were identical in appearance 
(Figure 2). When the SDS-P. haemolytica was immunoblotted with ~ab Ell, 
there were seven protein bands recognized ranging in size from 40 kDa to 
larger than ll6 K (Figure 3). The P1D~ with 15% F13S negative control 
demonstrated one protein band seen at 66 kDa which was consistently seen 
in the immunoblots with negative and positive control mouse sera, and 
the hyper immune bovine serum to P. haemo 1 yt ica. This band was 
disregarded henceforth and thougl}t to be due to reactions with 
Figure 1. Flow chart of the or~g~n and subsequent characterization of 
each of the four chosen monoclonal antibodies 
aMosier, et al. (1986). 
bGentry, et al. (1986). 
cBaluyut, et al. (1981). 
Fusions 1 through 4 
Initial hybridomas screened using partially-purified leukotoxina 
1.104 
1.22 
1.213 ______________________________ ~ 
I 
Screened and cloned three times 1.213 
using partially-purified leukotoxina Retrieved from frozen stock of 
initial hybridomas 
I . 
1.104 ClODlOAlO 1.22 Cl2B6G9 1.213 GllHllBl Screened and cloned two t1mes 
using lactoferrin-leukotoxinb 
All three screened using RPMI-leukotoxinc and 
sonicated ~ haemolytica antigens 




Screened and cloned once using 
RPMI-leukotoxinc and sonicated 
~ haemolytica antigens 
I 
























OD Reading of 
Mouse Media 
Hybridoma Sera Control 
1,999E 1.999E 0.057 
1.999E 1.096 0.052 
1. 716 0.653 0,012 
1.569 0.525 0.030 
1.999E 1. 671 0.056 
1,999E 1.628 0.062 
0,869 1.478 0.031 
0.861 1.615 0.026 
1.678 1.623 0.038 
0,980 1. 293 0.081 
1,999E 1.615 0.076 
1. 730 1. 623 0.062 
TABLE III 







































10 ug/ ml 
Limiting Dilution 
Maximum Probability of 
More Than a Single 
Cells/Well Clone/Well 
0.50 0,09 
1. 50 0.59 









1.00 o. 26 
*All screening was accomplished using the ELISA, Optical densities were read at 405 nm. 
aMosier, et al. (in press). 
bGentry, et al. (in press), 
















+ ~ouse serum 
- "Mouse serum 
TABLE IV 
SUMMARY OF THE REACTION JF THE VARIOUS ANTIGEN 
PREPARATIONS USED IN THE SCREENING AND 
CHARACTERIZATION OF EACH MONOCLONAL 
ANTIBODY 
Partially- 6-Hour 
Purified Sonicated Saline RP'1I-
Leukotoxina P.Haemolytica Extractb Leukotoxinc 
0.700 1. 584 0.503 0.419 
0. 038 0.100 0.034 0.032 
o. 439 0.009 0.061 0.083 
0.548 0. 017 0.078 0.058 
0.030 0.081 0.062 0.076 
1.999E 0.596 1.396 0.660 











*All screening was accomplished us~ng the ELISA. Optical densities were 
read at 405 nm. 
aMosier, et al. (1986). 
bLessley, et al. (1985). 
cBaluyut, et al. (1981). 
dsquire, Smiley and Croskell (1984). 
Figure 2. Sodium-Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
of the Various Antigen Preparations 
A: SDS-PAGE Electrophoresis of 1uter Membrane Protein 
Antigens obtained from Squire, Smiley and Croskell 
(1984). 
B: SDS-PAGE Electrophoresis of sodium chloride extracted 
capsular antigens obtained from Lessley, et al. (1985). 
C: SDS-PAGE Electrophoresis of sonicated ~ haemolytica 
antigen preparation. 
D: SDS-Page Electrophoresis of SDS-~ haemolytica antigen 
preparation. 
Arrows indicate molecular weights of (top to bottom): 
116 kDa, 66 kDa, 36 kDa, 29 kDa 
38 
Figure 3. ~-lest ern Imm.unob lots of the Sodium-Dodecyl Su 1 fate-P. 
haemolytica antigen preparations 
A. Amido black stain of antigen. 
E. Immunoblotted with Mab Ell. 
C. Imm.unoblotted with positive mouse serum. 
D. Imm.unoblotted with negative mouse serum. 
*Band not seen at approximately 100 kDa. 
E. Immunoblotted with bovine hyperimmune serum. 
F. Immunoblotted with 15% FBS in I~DM (negative control). 
Arrows indicate molecular weights of (top to bottom): 
116 kDa, 66 kDa, 36 kDa, and 20 kDa 
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antibodies in the IgG1 subclass foun-:1 in the FBS (data not shown). The 
hyperimmune bovine serum to ~ haemolytica had three distinct bands to 
the SDS-~ haemolytica antigen. Two of the three bands were seen at 
approximately 11~ kDa in the immunoblot with positive mouse serum. One 
band at approximately 60 kDa was seen in common with the immunoblot to 
Mab Ell. ~ab Ell had minimal reaction to the saline extract antigen and 
the outer membrane protein antigen. The immunoblot of ~ab Ell to RPMI-
leukotoxin (data not shown) was difficult to interpret due to the 
nonspecific binding of the streptavidin-biotinylated enzyme co~plex to 
the biotin found in the RPMI 1640 medium. 'Mab A.lO, Mab G9, and Mab 131 
demonstrated only one band at 66 kDa (data not shown) similar to that 
demonstrated with IMDM with 15% FBS. These latter three monoclonal 
antibodies were not further characterized. 
Reduction of the antigen preparations with sodium m-periodate prior 
to incubation with ~ab Ell failed to substantially alter the on405 
values compared to the nonreduced antigen preparations (Table V). These 
results indicate the epitope seen by Mab Ell was not influenced by any 
carbohydrate moiety. 
Clones of Mab Ell were characterized as IgM (Table VI). Quantita-
tion of Mab Ell indicated that the monoclonal antibody supernatants 
contained approximately 13 ug of immunoglobulin per ml. 
Slchromium Release Assay 
The results of the 51 chromium (51 cr) release assay are tabulated on 
Table VII. The hyperimmune bovine serum positive control showed neutral-
ization of a 1:4, 1:16, and 1:64 dilution of the leukotoxin. Neither 
TABLE V 




+ Mouse Serum 
15% FBS 
Before Periodate Treatment 
6-Uour 
Saline Antigen Sonicated 
Capsular Extracta Preparationb Antigen 
0.813 0.486 1.420 
1. 999E 1. 999E 1. 999E 
o. 011 0.017 0.008 
After Periodate Treatment 
6-Hour 
Saline Antigen Sonicated 
Capsular Extracta Preparationb Antigen 
0.861 0.593 1.142 
1. 999E 1. 999E 1. 999E 
0.001 0.006 0.004 
*Data is expressed as optical densities obtained by the ELISA method read at 405 nm before and after 
treatment with sodium m-periodate. 
aLessley, et al. (1985). 


















ISOTYPING OF Mab Ell* 
Optical Density Readings 















*Optical densities determined by ELISA read at 490 nm. 
Control 
Samples 
PBS - cells 
NaOH - cells 
RPMI - cells 
Ell-PBS 
Hyperimmune bovine serum 
-Leukotoxin (1:4) 
Hyperi~mune bovine serum 
-Leukotoxin (1:16) 













Ell-leukotoxin (1: 4) 1308.3 
Ell-leukotoxin (1:16) 1267.0 






















the FBS negative control nor the Mab ~11 neutralized any of the dilu-
tions of leukotoxin. 
Monoclonal Cross Reactivity to Other Gram 
Negative Organisms 
~Ab Ell was reactive to several other gram negative organisms using 
the immunofluorescence technique (Table VIII). Cross reactivity was 
seen very intensely with Haemophilus influenza and less intensely with 
Pasteurella multocida (Figure 4). Mab Ell reacted diffusely with the 
cell wall of!:_ haemolytica and more irregularly with the cell walls of 
the other two bacteria. 
TABLE VIII 
IMMUNOFLUORESCENCE OF ~ONCLONAL A~TIBODY Ell TO 


















*The grading scale was similar to that used to grad,e 
groups A and B streptococci.(Manual of Clinical 
Microbiology, 1980). 
Figure 4. Immunofluorescence of Monoclonal Antibody Ell against P. 
haemolytica and Hemophilus influenza 
Top Photo: Immunofluorescence with P. haemolytica 
Bottom Right Photo: Immunofluorescence with Hemophilus 
influenza 




Electron Microscopy of ~ haemolytica 
P. haemolytica was evaluated with Mab Ell by electron microscopy. 
Mab Ell did not bind to intact bacterial cell walls, but was seen within 
the cell boundaries when the membranes were disrupted (Figures 5 and 6). 
The pattern of antibody binding appeared in aggregations throughout the 
cytoplasm and not a diffuse pattern. The I'1DT\f with 15% F"BS negative 
control in Figure 7 revealed pores seen in an intact bacterial cell wall 
with disruption of the adjacent wall. There was no binding of colloid 
gold within any sections of the negative control examined. 
Figure 5. Electron microscopy of Monoclonal Antibody Ell and P. 
haemolytica using colloid gold as the electron de~e 
indicator. (Magnification 60,000 x; 1 mm = 0. 017 u) 
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Figure 6. Electron microscopy of Monclonal Antibody Ell and P. 
haemolytica using colloid gold as the electron danse 
indicator. (Magnification 72,000 x; 1 mm = 0.014 u) 
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Figure 7. Electron microscopy of negative control fetal bovine serum 
media and P.haemolytica using colloid gold as the 
electron dense indicator. (Magnification 42,000 x; 1 mm 




A monoclonal antibody (Ell) ~ haemolytica was produced. The ELISA 
was used for screening hybridomas for antibody to ~ haemolytica. There 
are both advantages and disadvantages to this system. It is advantageous 
in that it is economical, efficient, and can screen large numbers of 
samples (Voller, 1979}. The disadvantages included the presence of 
small amounts of extraneous serum proteins in the screening antigen 
preparations used in this study. Therefore, there was no ability to 
differentiate antibody responses to these proteins from responses to ~ 
haemolytica antigens. In addition, it has been suggested that assays 
using antigen adsorbed to a solid support should not be used to screen 
monoclonal antibodies that will be used to detect soluble antigens, such 
~as leukotoxin, because of conformational changes that can' occur when 
solute antigens are adsorbed onto solid supports (Vaidya, Dietzler and 
Ladenson, 1985). Due to the difficulty in purifying the ~ haemolytica 
leukotoxin antigen, the use of functional assays for screening would be 
more appropriate in detecting antibody of the desired specificity. The 
most appropriate functional assay is the detection of neutralizing anti-
bodies against the leukotoxin. 
Three of the four chosen hybridomas screened in this study seemed 
to produce antibodies that reacted with either nonbacterial proteins or 
proteins which eras s react to bacteria 1 antigens present in the 
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antigenic preparations. Three observations suggust this cone 1 us ion. 
The preliminary Western immunoblots using the polyclonal hybridoma fluid 
to react with BSA and partially-purified leukotoxin were nearly identi-
cal (data not shown), although this does not rule out the possibility 
that the leukotoxin co-migrated with a protein of the same molecular 
weight as BSA. Secondly, in ELISA using purified lactoferrin as the 
coating antigen and hybridoma fluids, there was a a high oo405 reading 
to lactoferrin. Thirdly, the ELISA there was a high on 405 reading to 
the lactoferrin and partially-purified leukotoxin prepara-tions but a 
low on 405 reading to the sonicated~ haemolytica or RP\fi-leukotoxin 
preparations when reacted with the four monoclonal antibodies. 
The rationale for using a lactoferrin-leukotoxin to screen the 
hybridomas was to avoid reactivity to BSA that was apparently present in 
the partially-purified leukotoxin used to immunize the mice. Cross 
reactions of the hybridoma findings with the lactoferrin protein in the 
lactoferrin-leukotoxin screening antigen may have occurred by two 
possible mechanisms (Goding, 1983). First, the monoclonal antibody may 
have recognized a structurally similar, nonidentical determinant which 
allows detectable binding, although possibly at a lower affinity. The 
second possible mechanism is that the monoclonal antibody may be 
multispecific and recognize two or more epitopes by binding to unrelated 
antigens with different affinities and types of interactions (i.e. 
electrostatic, hydrogen bonding, Van der 1-laals, or hydrophobic effects). 
Cons i:iering the large number of bio 1 og ica 1 macromo 1 ecu 1 es, the 
specificity of a given monoclonal antibody is not expected to be 
absolute. 
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To aid in the characterization of Mab Ell, an SDS-!:_ haemolytica 
extract, a saline extract, and outer membrane antigen preparations were 
used. Mab Ell recognized a noncarbohydrate epitope associated with seven 
protein bands in the SDS-P. haemolytica antigen preparation. The multi-
ple number of protein bands is a result of a common recognition site on 
many differently sized protein molecules. One can only speculate as to 
their origin. It is possible the repeated epitope sites ·were to a common 
protein which the bacteria proteolytically auto-degraded. ~!though ~ab 
Ell reacted significantly to both the outer membrane and saline extract 
antigen preparations in the ELISA, ~inimal reaction was detected to 
these two antigens on the Western immunoblot. Possible reasons for this 
difference in reactivity could re 1 ate to the nature of a monoc 1 ona 1 
antibody and its relationship to an epitope. Conventional polyclonal 
antisera contains thousands of different antibody clones allowing the 
binding of antigenic determinants covering most or all of the external 
surface of the antigen. Therefore, small changes in the structure of the 
antigen due to denaturation usually has little effect on the binding of 
polyclonal antibodies (Goding, 1983). However, monoclonal antibodies 
usually bind a unique site on the protein molecule of the antigen. If 
this site is altered in any way, such as by SDS and heating, the anti-
body binding site may be destroyed. In the ELISA system, the native 
protein is in its three dimensional structure. With the Western im~uno­
blot, the protein structure has undergone denaturation and may be in a 
linear configuration. Whether or not a conformational epitope can refold 
following heat and SDS treatment may change the reactivity of an anti-
body. If the antigenic sites depend on the three dimensional 
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conformation of the protein or epitope that is denatured and cannot 
refold, antibody binding cannot occur. 
As seen by immunofluorescence, the fluorescence pattern with Mab Ell 
and P. haemolytica is suggestive of a structural membrane component of 
the bacteria. There is also a reaction of the Mab Ell with P. multocida 
and Hemophilus influenza. This suggests that there is a common epitope 
found among these three bacteria. By electron microscopy, antibody 
specificity appeared to be to an intracellular component. The differ-
ences between antibody patterns of the immunofluorescence and the 
electron microscopy are possibly due to the differences in bacterial 
fixation, behavior of the antigenic protein, or a concentration depend-
ent aggregation of the colloidal gold. The formaldehyde concentrations 
used to fix the bacterial cells for electron microscopy could have 
potentially changed antigenic epitopes on the cell surface thereby 
changing the antibody binding site at the cell periphery. The antibody 
around the cell periphery with immunofluorescence could be either local-
ized within the cell wall, periplasma, or cytoplasmic membrane. Further 
electron microscopic studies are needed to evaluate this discrepancy 
from the immunogluorescence studies. 
Mab Ell has already been used, through the process of its own 
characterization, to, in turn, help characterize the ~ haemolytica 
antigen preparations available. The noncarbohydrate epitope recognized 
was most likely a structural protein found in many ~_haemolytica 
antigen prepar~tions. The fact that several protein bands reacted with 
the antibody might be explained by proteolytic degradation of bacterial 
proteins in the antigen preparations. ~ab Ell did not recognLze an 
epitope when the saline extract and outer membrane protein antigens were 
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denatured but bound to antigenic epitopes in the nondenatured configura-
tion. The epi tope was one also found on H. influenza and P. mu 1 tocida 
whole organisms. Mab Ell recognized the three dimensional conformation 
on the epitope sites on whole organisms as well as six protein bands on 
the denatured whole organism. 
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